Clinical Trials Browser

Phase 1/2 × Patient Participation × Bortezomib × Clear all

NCT00985907 2020-06-17

DMV

Phase 1/2 Terminated

13 enrolled 8 charts

Multiple Myeloma, Patient Participation, Neoplasms, Plasma Cell